BEIJING (Reuters) – China opposes accusations and the shifting of responsibility on the issue of fentanyl-related substances, according to an official white paper released on Tuesday, Xinhua reported.
China has carried out “in-depth” cooperation with relevant countries, including the U.S., in addressing the issue of fentanyl-related substances and their precursors, the white paper said, adding that cooperations have “achieved significant results”.
U.S. President Donald Trump increased tariffs on all Chinese imports to 20% from the previous 10% levy on Tuesday to punish Beijing for failing to halt shipments of the deadly opioid fentanyl to the U.S.
(Reporting by Xiuhao Chen and Ryan Woo, Editing by Louise Heavens)
Comments